Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 669-676

  Selby, Mark ^a   Erickson, Ann ^a   Dong, Christine ^a   Cooper, Stewart ^b   Parham, Peter ^b   Houghton, Michael ^a   Walker, Christopher M ^a,c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b STANFORD UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HEPATITIS C VIRUS; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; VIRUS ENVELOPE;

ANIMALS; ANTIGEN PRESENTATION; ASPARAGINE; CELL LINE; CYTOPLASM; CYTOTOXICITY, IMMUNOLOGIC; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; LIVER; LYMPHOCYTE ACTIVATION; PAN TROGLODYTES; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL ENVELOPE PROTEINS;

EID: 0033555404     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Heemels, M.-T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class-I restricted peptides. Annu. Rev. Biochem. 64:463.
2. Elliott, T. 1997. Transporter associated with antigen processing. Adv. Immunol. 65:47.
3. York, I., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
4. Siliciano, R. F., and M. J. Soloski, 1995. MHC class 1-restricted processing of transmembrane proteins. J. Immunol. 95:2.
5. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.
6. + T cells. Nature 364:158.
7. Lee, S. P., W. A. Thomas, N. W. Blake, and A. B. Rickinson. 1996. Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2. Eur. J. Immunol. 26:1875.
8. Henderson, R. A., A. L. Coss, K. Sakaguchi, E. Appellia, J. Shabanowitz, D. H. Hunt, and V. H. Engelhard. 1993. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1 specific cytotoxic T cells. Proc. Natl. Acad. Sci. USA 90:10275.
9. + CTL. J. Immunol. 154:6140.
10. Ferris, R. L., C. Buck, S. A. Hammond, A. S. Woods, R. J. Cotter, M. Takiguchi, Y. Igarashi, Y. Ichikawa, and R. F. Siliciano. 1995. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. J. Immunol. 156:834.
11. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type I recombinant human immunodeficiency virus envelope glycoprotein (gp120) expression Chinese hamster. J. Biol. Chem. 265:10373.
12. Boon, T., and A. Van Pel. 1989. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions: a hypothesis. Immunogenetics 29:75.
13. Yewdell, J. W., J. C. Antón, and J. R. Bennink. 1996. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J. Immunol. 157:1823.
14. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibilily complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
15. Wiertz, E. J. H., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class 1 heavy chains from the endoplasmic reticulum of the cytosol. Cell 84:769.
16. Wiertz, E. J. H., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T.R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432.
17. Hiller, M. M., A. Finger, M. Schweiger, and D. H. Wolf. 1996. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 273:1725.
18. Werner, E. D., J. L. Brodsky, and A. A. McCracken. 1996. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc. Natl. Acad. Sci. USA 93:13797.
19. Hughes, E. A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94:1896.
20. Yu, H., G. Kahung, S. Kobayashi, and R. R. Kopito. 1997. Cytosolic degradation of T-cell receptor α chains by the proteasome. J. Biol. Chem. 272:20800.
21. Bacik, I., H. L. Snyder, L. C. Anton, G. Russ, W. Chen, J. R. Bennink, L. Urge, L. Otvos, B. Dudkowska, L. Eisenlohr. et al. 1997. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J. Exp. Med. 186:479.
22. Skipper, J. C. A., R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Van Pel, Y. Chen, J. Shabanowitz, T. Wolfel, C. L. Slingluff, T. Bonn, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from post-translational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183:527.
23. Mosse, C. A., L. Meadows, C. J. Luckey, D. Kittlesen, E. L. Huczko, C. L. Slingluff, Jr., J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1998. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187:37.
24. Suzuki, T., A. Seko, K. Kitajima, Y. Inoue, S. Inoue. 1993. Identification of peptide:N-glycanase activity in mammalian-derived culture cells. Biochem. Biophys. Res. Commun. 194:1124.
25. Suzuki, T., A. Seko, K. Kitajima, Y. Knoue, and S. Inoue. 1994. Purification and enzymatic properties of peptide:N-glycanase from C3H mouse-derived L-929 fibroblast cells. J. Biol. Chem. 269:17611.
26. Koziel, M. J., D. Dudley, J. T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B. D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339.
27. Koziel, M. J., and B. D. Walker. 1997. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection. Springer Semin. Immunopathol. 19:69.
28. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Normura, H. Miura, I. Nakamura, Y. Yazaki, and M. Imawari. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039.
29. Shirai, M., H. Okada, M. Nishioka, T. Akatsuka, C. Wychowski, R. Houghten, C. D. Pendleton, S. Feinstone, and J. A. Berzofsky. 1994. An epitope in hepatitis C core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:3334.
30. Cerny, A., J. G. McHutchinson, C. Pasquinelli, M. E. Brown, M. A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F. V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521.
31. Battegay, M., J. Fikes, A. M. Di Bisceglie, P. A. Wentworth, A. Sette, E. Celis, W. Ching, A. Grakoui, C. M. Rice, and K. Kurokohchi. 1995. Patient with chronic hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2462.
32. Erickson, A. L., M. Houghton, Q.-L. Choo, A. J. Weiner, R. Ralston, E. Muchmore, and C. M. Walker. 1993. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J. Immunol. 151:4189.
33. + cytotoxic T cells from two chronically infected chimpanzees. J. Exp. Med. 183:1761.
34. Walker, C. M. 1996. Cytotoxic T-lymphocyte responses to the hepatitis C virus in humans and chimpanzees. Semin. Virol. 7:13.
35. Banks, T. A., F. J. Jenkins, S. Kanangat, S. Nair, S. Dasgupta, C. M. Foster, and B. T. Rouse. 1994. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-I) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge. Virology 200:236.
36. Weiner, A., A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, and C. M. Walker. 1995. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl. Acad. Sci. USA 92:2755.
37. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411.
38. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
39. Tobery, T. W., and R. F. Siliciano. 1997. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185:909.
40. Choo, Q.-L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, A. Medina-Selby, P. J. Barr, et al. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451.
41. Ralston, R., K. Thudium, K. Berger, C. Kuo, B. Gervase, J. Hall, M. Selby, G. Kuo, M. Houghton, and Q.-L. Choo. 1993. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. 67:6753.
42. Spaete, R. R., D. Alexander, M. E. Rugroden, Q.-L. Choo, K. Berger, K. Crawford, C. Kuo, S. Leng, C. Lee, R. Ralston, et al. 1992. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 188:819.
43. Matlack, K. E., W. Mothes, and T. A. Rapoport. 1998. Protein translocation: tunnel vision. Cell 92:381.
44. Rapoport, T. A., B. Jungnickel, and U. Kutay. 1996. Protein transport across the eukaryotic endoplasmic reticulum and bacterial inner membranes. Annu. Rev. Biochem. 65:271.
45. Hanein, D., K. E. S. Matlack, B. Jungnickel, K. Plath, K.-U. Kalies, K. R. Miller, T. A. Rapoport, and C. W. Akey. 1996. Oligomeric rings of the Sec61p complex induced by ligands. Cell 87:721.
46. Morrison, L. A., A. E. Lukacher, V. L. Braciale, D. P. Fan, and T. J. Braciale. 1986. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J. Immunol. 163:903.
47. Townsend, A. R., J. Bastin, K. Gould, and G. G. Brownlee. 1986. Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 324:575.